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We report the immediate effects of estrogen signaling
on the transcriptome of breast cancer cells using
global run-on and sequencing (GRO-seq). The data
were analyzed using a new bioinformatic approach
that allowed us to identify transcripts directly from
the GRO-seq data. We found that estrogen signaling
directly regulatesastrikingly large fractionof the tran-
scriptome in a rapid, robust, and unexpectedly tran-
sient manner. In addition to protein-coding genes,
estrogen regulates the distribution and activity of all
three RNA polymerases and virtually every class of
noncoding RNA that has been described to date.
We also identified a large number of previously unde-
tected estrogen-regulated intergenic transcripts,
many of which are found proximal to estrogen
receptor binding sites. Collectively, our results
provide the most comprehensive measurement of
the primary and immediate estrogen effects to date
anda resource for understanding rapid signal-depen-
dent transcription in other systems.
INTRODUCTION
The steroid hormone estrogen, acting through estrogen recep-
tors (ERs), plays key roles in a variety of fundamental develop-
mental and physiological processes, as well as many disease
states (Deroo and Korach, 2006). Mammals express two ER iso-
forms, ERa and ERb, which exhibit distinct tissue-specific
expression patterns and biological roles (Deroo and Korach,
2006;Warner et al., 1999). ERs function primarily as nuclear tran-
scription factors, which dimerize upon binding of the natural
ligand, 17b-estradiol (E2), and act as potent regulators of gene
expression. ERa binds to > 10,000 sites across the genome
and acts to (1) promote the recruitment of coregulators that622 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.mediate posttranslational modification of histones or other tran-
scription factors and (2) regulate the binding or activity of the
RNA polymerase II (Pol II) transcriptional machinery, ultimately
altering the transcriptome in estrogen-responsive cells (Acevedo
and Kraus, 2004; Cheung and Kraus, 2010; Ruhl and Kraus,
2009).
Previous studies analyzing steady-state gene expression
patterns in the presence and absence of E2 have failed to reveal
a consistent view of the estrogen-regulated gene set. In partic-
ular, the use of expression microarrays has produced discrep-
ancies in the numbers of estrogen-regulated genes in the widely
used ERa-positive MCF-7 human breast cancer cell line, ranging
from 100 to 1500 (Cheung and Kraus, 2010; Kininis and Kraus,
2008). In addition, genomic ChIP analyses of ERa and Pol II
have not produced a clear picture of the estrogen-regulated
gene set either. This is due, in part, to the difficulty in assigning
ERa binding events to specific gene regulatory outcomes
(Carroll et al., 2006; Welboren et al., 2009). Another limitation
of these analyses is that they have focused on the effects of
estrogen signaling on Pol II transcription, without considering
potential effects on Pol I and Pol III.
A fundamental weakness that is inherent in monitoring
estrogen-dependent gene expression by assessing changes in
mature mRNA is that longer treatments are required to allow
time for mRNA accumulation (3–24 hr). This time allows the
accumulation of transcripts from primary ERa target genes but
also leads to a host of secondary transcriptional effects that are
not directly mediated by ERa. To address these concerns,
preliminary attempts to define the immediate transcriptional
effects of estrogen signaling using the translation inhibitor cyclo-
heximide indicated that only 20%– 30% of the genes showing
changes in expression are primary targets (Lin et al., 2004). Using
cycloheximide to infer primary estrogen target genes is problem-
atic, however, because (1) cycloheximide does not inhibit the
effects of noncoding regulatory RNAs on gene expression, which
is becoming widely recognized as an important mechanism
underlying the regulation of many genes (Krol et al., 2010), and
(2) the levels of steady-state mRNA depend not only on
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Figure 1. GRO-Seq Provides a Detailed View of the E2-Regulated Transcriptome in MCF-7 Cells
(A) Overview of the experimental set-up for GRO-seq analysis using MCF-7 cells.
(B) Genome browser view for a specific locus showing GRO-seq (top) and Pol II ChIP-seq (bottom) data illustrating the features of transcription and the effects
of estrogen treatment.
(C) De novo detection of transcripts using GRO-seq data (top) and an HMM (inset). Called transcripts (middle) match well to RefSeq annotations (bottom).
(D) Classification of transcripts based on the annotation filter (Figures S1E and S1F).
See also Figure S1.transcriptional regulation by E2, but also on the rates of elonga-
tion, pre-mRNA processing, and mRNA degradation (Widelitz
et al., 1987). Due to these factors, it is clear that a new approach
is required to conclusively identify primary estrogen target genes.
Here, we used global nuclear run-on and sequencing
(GRO-seq) (Core et al., 2008) to identify the immediate effects
of estrogen signaling on the entire transcriptome in MCF-7 cells.
GRO-seq is a direct sequencing method that provides a ‘‘map’’
of the position and orientation of all engaged RNA polymerases
across the genome at extremely high resolution, providing
a directmeasure of transcription. UsingGRO-seq in combination
with a bioinformatic approach based on hidden Markov models
(HMMs), we determined all (i.e., both annotated and unanno-
tated) genomic regions in MCF-7 cells that are transcribed by
Pols I, II, and III. In addition, we identified the primary transcrip-
tional targets of E2 signaling by focusing on short treatments
(i.e., 0, 10, and 40 min) prior to the activation of secondary
targets. Our unique approach has revealed many unexpected
features of E2-regulation, providing the most comprehensivemeasurement of the primary and immediate effects of E2
signaling to date. Our results provide a model and resource for
understanding rapid signal-dependent transcription in other
systems.
RESULTS AND DISCUSSION
Generation of GRO-Seq Libraries from Estrogen-
Treated MCF-7 Cells
To investigate the immediate effects of estrogen on the tran-
scriptome of human cells, we treated estrogen-deprived
ERa-positive MCF-7 human breast cancer cells with a short
time course of 17b-estradiol (E2) (0, 10, 40, and 160 min) (Fig-
ure 1A). The estrogen-deprived MCF-7 cells continued to grow
actively (Figure S1A available online), and the population of cells
showed a normal distribution through the cell cycle (Figure S1B).
Nuclei were isolated from two biological replicates of the
E2-treated MCF-7 cells and subjected to the GRO-seq proce-
dure to generate 100 bp libraries representing nascent RNAs,Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc. 623
which were sequenced using an Illumina Genome Analyzer (Fig-
ure 1A). Short-reads were aligned to the human reference
genome (hg18, NCBI36), including autosomes, the X chromo-
some, and one complete copy of an rDNA repeat (GenBank ID:
U13369.1). Approximately 13 to 17 million reads were uniquely
mapped to the genome for each treatment condition, and the
biological replicates for each time point were highly correlated
(average correlation coefficient = 0.98) (Figure S1C). GRO-seq
returns data from all three RNA polymerases (Pols I, II, and III).
To validate whether the reads mapping to the supposed loci
transcribed by Pols I, II, and III were correlated with the activities
of each individual RNA polymerase, we carried out filter binding
assays with combinations of polymerase inhibitors to isolate
each polymerase. As expected, the activities detected by the
filter binding assays were comparable to GRO-seq product frac-
tion, with a slight underrepresentation of the apparent fraction of
Pol I transcripts by GRO-seq due to an enrichment of positions
that are not mappable in the repetitive rDNA sequences
(Figure S1D).
Figure 1B (top) shows a representative histogram of read
counts versus genomic position for a locus containing the
LHX4 and ACBD6 genes. Key features of the data set are illus-
trated in this representation, including strand-specific transcrip-
tion, divergent transcription near transcription start sites (TSSs),
and robust E2-dependent induction for some genes (e.g., LHX4).
These features are not readily apparent in ChIP-seq data from
the same region (Figure 1B, bottom).
Unbiased Assignment of GRO-Seq Reads to Specific
Transcripts
To determine the effects of E2 on the entire transcriptome (i.e.,
annotated and unannotated; coding and noncoding), we devel-
oped an unbiased approach for calling transcripts using a two-
state HMM. The model takes as input information about read
counts across the genome and subsequently divides the
genome into two states representing ‘‘transcribed’’ and ‘‘non-
transcribed’’ regions (Figure 1C, inset; see Supplemental
Information for additional details). An example of the input and
output of this algorithm for a gene-rich region of the genome is
shown in Figure 1C. The top panel shows the raw sequence
read counts for the GRO-seq data, the middle panel shows the
predicted transcripts, and the bottom panel shows the RefSeq
annotations.
To evaluate the robustness of our approach, we compared our
predicted transcript calls to existing annotations when these
were available (see Supplemental Information for details). First,
we determined whether our predictions reflect entire transcripts,
as opposed to breaking each gene up into a series of smaller
units. Then, we determined whether our approach can accu-
rately identify nontranscribed intervals between neighboring
but distinct gene annotations. We found that 90% of transcribed
annotated genes overlap with exactly one transcript and that
82% of called transcripts overlapping an annotated gene do so
with exactly one annotation. Together, these results suggest
that our HMM-based transcript calls largely recapitulate public
annotations. In many cases, our transcript calls provided new
or more refined information about TSSs, 50 exons, and transcrip-
tion termination sites than was available in existing databases.624 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.Using our algorithm, we assigned the genomic reads into
22,893 transcripts at one or more points during the E2 treatment
time course, covering 27% of the MCF-7 genome.
Transcripts called by the HMM were divided using a heuristic
approach into six distinct, nonoverlapping classes, which
describe the best classification of each transcript given currently
available annotations and other information (Figures S1E and
S1F; see Extended Experimental Procedures for additional
details). The six classes of transcripts that we defined are illus-
trated in Figure 1D and include: (1) annotated genic and noncod-
ing RNA transcripts, (2) antisense (genic) transcripts, (3) diver-
gent transcripts, (4) ERa enhancer transcripts, which likely
correspond to the recently described enhancer RNAs (Kim
et al., 2010), (5) other transcripts falling into annotated regions
but poorly matching the annotation, and (6) completely unanno-
tated, intergenic transcription. Although each transcript is as-
signed to only one of these six classes, within each class,
multiple annotations could be applied, allowing the accurate
annotation of miRNA genes that fall inside of the introns of
protein-coding genes. We found that 50.1% of the called tran-
scripts map to previously annotated genes or noncoding
RNAs, 5.2% map to antisense transcripts, 16.4% map to diver-
gent transcripts, 6.8% map to ERa binding enhancers,
and 12.1% are entirely unannotated intergenic transcripts
(Figure 1D).
Extensive Estrogen-Dependent Changes in the MCF-7
Transcriptome
We determined which of the 22,893 transcripts change in
response to E2 using a recently described model-based
approach (Robinson et al., 2010) that detects changes beyond
the global level of variation (Figure S2A; see Experimental
Procedures for details). We focused our analysis on a 12 kb
window at the 50 end of each transcript, as we expect to observe
changes during the first 10 min in this window that will not yet
have spread to the 30 end of longer transcripts. Surprisingly,
we found that transcription of an unexpectedly large fraction
(26%) of the MCF-7 transcriptome is altered (up- or downregu-
lated relative to the control/untreated condition) upon E2
treatment for at least one point in the time course (Figure 2A;
comparisons are relative to the untreated condition). Large frac-
tions of the genome are regulated even for the short treatments
used in our experiments, strongly suggesting that these are
direct actions of ERa. For example, at 10 min of E2 treatment,
almost 10% of the MCF-7 cell transcriptome was significantly
regulated at a false discovery rate of 0.1% (Figure 2B). Another
surprising finding concerns the dynamics of regulation for up-
and downregulated transcripts. Through 40 min of E2 treatment,
the time point at which the largest number of transcripts were
regulated in our analyses, roughly equal numbers were upregu-
lated and downregulated, but by 160 min 75% of the tran-
scripts were downregulated (Figure 2B). Those transcripts
showing regulation at 10 or 40 min represent the most compre-
hensive and accurate definition of the immediate transcriptional
targets of the estrogen-signaling pathway described to date.
Next, we examined the regulation of the different classes of
transcripts in greater detail. Annotated protein-coding and func-
tional RNA transcripts as a group, as well as those unannotated
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C Figure 2. A Large Fraction of the MCF-7
Transcriptome Is Regulated by Estrogen
(A) The fraction of all transcripts that are regulated
by E2 at any time point.
(B) The fraction of all transcripts that are up- or
downregulated by E2 at the time point shown.
(C) Heatmap representations of time-dependent
regulation by E2 for each transcript class. Values
are centered and scaled to the 0 min time point.
(D) The fraction of each class of transcript that is
up- or downregulated by E2 at each time point.
See also Figure S2.transcripts with possible roles in gene regulation (e.g., divergent
and antisense), had approximately equal numbers of upregu-
lated and downregulated transcripts at 40 min (Figures 2C and
2D). In contrast, the ERa enhancer transcripts were predomi-
nately upregulated, whereas the intergenic transcripts were
predominantly downregulated. Together, these results suggest
a coordinated transcriptional response in which E2 signaling
directs the transcriptional machinery from intergenic regions to
those more critical to the estrogen response. In addition, they
give a fundamentally different view of estrogen-regulated gene
expression than has been obtained using expression microar-
rays, especially with respect to the timing,magnitude, and extent
of regulation.
Regulation of Unannotated Noncoding Transcripts
by Estrogen: Divergent, Antisense, and Intergenic
Transcripts
Our GRO-seq data revealed extensive estrogen regulation of
a large set of unannotated noncoding transcripts, including
divergent, antisense, and intergenic transcripts. Although theCell 145, 622–functions of these transcripts are largely
unknown, their regulation by E2 suggests
a role in estrogen-dependent transcrip-
tional responses. The production and
accumulation of divergent transcripts
were first documented in recent studies
using high-throughput genome-wide
sequencing approaches with human
fibroblasts (Core et al., 2008) and mouse
embryonic stem cells (Seila et al., 2008).
Divergent transcripts are transcribed in
the opposite direction from primary tran-
scripts at the promoters of transcribed
genes and are also produced at
enhancers (e.g., eRNAs; Kim et al.,
2010) and other unannotated regions
that are transcribed. The function of
divergent transcripts is unknown, but
their production has been suggested to
promote an open chromatin architecture
at promoters through the generation of
a nucleosome-free region or negative
superhelical tension (Core et al., 2008;
Seila et al., 2008, 2009). We identified518 divergent transcripts associated with the promoters of
protein-coding genes, enhancers, and other unannotated tran-
scribed regions that are regulated by E2 for at least one time
point (FDR q value < 0.001). Using these annotations, we tested
whether production of a given E2-regulated divergent transcript
correlates with the synthesis of the corresponding primary tran-
script. To do so, we tested 844 primary/divergent transcript pairs
for which either the divergent, primary, or both transcripts were
regulated by E2 for at least one time point. As shown in Fig-
ure S2B (left), E2-dependent changes in divergent transcription
were strongly correlated with E2-dependent changes in the cor-
responding primary transcripts (Pearson correlation: 0.744; p <
2.2 3 1016). This result is consistent with a role for divergent
transcription in facilitating E2-dependent transcription of the cor-
responding primary transcript.
Although not well characterized, antisense transcription has
been shown to have roles in the degradation of corresponding
sense transcripts (Katayama et al., 2005; Werner et al., 2009),
as well as gene silencing at the chromatin level (Liu et al.,
2010; Morris et al., 2008). Of 1197 transcripts annotated as634, May 13, 2011 ª2011 Elsevier Inc. 625
antisense to a protein-coding transcript, we identified 429 that
are regulated by E2 (FDR q value < 0.001) (Figure S2C). As
with the divergent transcripts, we determined whether produc-
tion of a given E2-regulated antisense transcript correlates with
the synthesis of the corresponding primary transcript. Based
on 582 sense/antisense transcript pairs, we found a remarkably
high correlation between genes and their antisense transcripts
(Pearson correlation: 0.654; p < 2.2 3 1016) (Figure S2B, right).
This is particularly surprising given that, unlike divergent tran-
scripts, antisense transcripts do not share a proximal promoter
with the sense transcript, although promoter-promoter contact
through genomic looping might allow for coordinated transcrip-
tional responses. If antisense transcripts play a role in the degra-
dation of the sense transcript, as has been suggested previously,
then their E2-dependent production may provide a ‘‘built-in’’
means of attenuating the steady-state levels of a select set of
estrogen-regulated transcripts.
We also identified 2761 transcripts that have no specific rela-
tion to previous genome annotations. Of these, 686 were regu-
lated by E2 for at least one time point. Interestingly, the vast
majority of these E2-regulated intergenic transcripts are downre-
gulated by E2 treatment (Figure 2D). The function of these tran-
scripts is unknown. Some may represent currently unannotated
protein-coding transcripts or functional RNAs. Ascribing a func-
tion to these RNAs and determining their relative stability in the
steady-state cellular RNA pool will require additional studies.
Their downregulation by E2, however, suggests a link to the
estrogen signaling program. Perhaps they act to antagonize
E2-dependent transcriptional responses and must be shut
down to achieve a full estrogen response. Alternatively, their
antagonism by E2 may be a passive effect of RNA polymerases
being diverted to bona fide transcriptional targets of the
estrogen-signaling pathway, as suggested previously (Carroll
et al., 2006).
Rapid, Extensive, and Transient Regulation of Protein-
Coding Transcripts by Estrogen
Numerous studies have examined the steady-state regulation of
protein-coding transcripts by E2 using expression microarrays
(Cheung and Kraus, 2010; Kininis and Kraus, 2008). Given the
sensitivity of our approach for detecting immediate transcrip-
tional changes in response to short E2 treatments, we extracted
and examined the protein-coding transcripts in our GRO-seq
data for comparison. We focused on annotations in the RefSeq
database because this set is among the most comprehensive
collection of transcripts and has extensive andwell-documented
overlap with expression microarrays. As noted above, we used
read counts in a 12 kb window at the 50 end of each annotation
and determined regulation by E2 using the edgeR package,
filtering for a false discovery rate of 0.1%.
Using this approach, we detected a total of 3098 protein-
coding transcripts whose levels changed relative to the control
(untreated) condition at one or more of the points in the E2 treat-
ment time course. In total, these transcripts represent 15% of
all genes annotated in RefSeq (33% of 9337 expressed genes)
that are responsive to E2. This is a considerably larger number of
genes than was detected previously at 1 or 3 hr of E2 treatment
using expression microarrays (Cheung and Kraus, 2010; Kininis626 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.and Kraus, 2008; Figure S3A). Surprisingly, we found 1000
genes total to be up- or downregulated after only 10 min of E2
treatment. We used hierarchical clustering to define four classes
of genes sharing similar patterns of regulation, including a class
of rapidly downregulated genes and three classes of genes with
maximal transcription at the three E2 treatment time points (10,
40, or 160 min) (Figures 3A and 3B). The downregulated class
was the largest, comprising 50% of the E2-regulated protein-
coding transcripts. The majority of genes in this class were
rapidly downregulated (by 10 min, on average) and tended
(with a few exceptions) to stay downregulated throughout the
time course. Upregulated genes with maximal transcription at
40 min were the second largest class, comprising 34% of the
E2-regulated protein-coding transcripts. Although the time
course of induction or repression varied among the four classes,
the magnitude of response did not differ between the classes
(Figure 3C). Interestingly, the genes in the ‘‘10 minute max’’
and ‘‘40 minute max’’ classes returned, on average, to the basal
levels of transcription by the end of the E2 treatment time course
(Figure 3B), highlighting the rapid and transient nature of the tran-
scriptional response for the majority of the upregulated genes.
Biologically relevant changes in transcription should be
accompanied, in most cases, by similar changes in the steady-
state level of the corresponding mRNA. We tested this expecta-
tion using both genomic and gene-specific comparisons. First,
we compared fold changes in primary transcription that were de-
tected using our GRO-seq data to fold changes at the level of
steady-state mRNA (3 or 12 hr of E2 treatment) from published
expression microarray data for MCF-7 cells. For the subset of
genes that we observed to be regulated by GRO-seq, we found
that the strongest correlations were between either the 40 or
160 min GRO-seq time points and the 3 hr microarray time point
(Figures S3B and S3C). Note, however, that there aremanymore
genes detected as E2 regulated by GRO-seq than by expression
microarray analyses (Figure S3A). If we limited the analysis to
only genes that change in the microarray analysis (FDR cor-
rected q value < 0.05), we see an even higher correlation
between GRO-seq and microarray data (Figure 3D; Spearman’s
correlation: 0.75). This analysis suggests that the early actions of
E2 are almost all mediated at the level of transcription and that E2
does not affect RNA stability or degradation rate directly. These
results provide a first indication that transcription, as determined
byGRO-seq, is propagated to changes in the steady-state levels
of the corresponding mRNAs.
Next, we randomly selected a set of 10 to 20 genes for each of
the four classes (54 genes total) and measured the relative
steady-state levels of mRNA from each gene over a 6 hr time
course of E2 treatment using RT-qPCR. In general, the changes
in transcription measured by GRO-seq were reflected in corre-
sponding changes in the steady-state mRNA levels measured
by RT-qPCR (Figure 3E and Figure S4). In almost all cases, we
observed a delay of 1–3 hr between the peak fold changes
measured by GRO-seq and RT-qPCR. This delay reflects the
time necessary for changes in Pol II (measured at the 50 end in
GRO-seq) to reach the 30 end of the gene and for mRNA to accu-
mulate (or degrade) by a detectable level. As with the compari-
sons to the microarray expression data, these results indicate
that changes in transcription are efficiently translated into
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Figure 3. GRO-Seq Identifies Four Distinct Classes of E2-Regulated RefSeq Genes
(A) Heatmap of the time course of E2-dependent regulation of RefSeq genes. Red numbers indicate the four different classes of regulation.
(B) Centered-scaled traces showing the regulation of the four distinct classes of E2 regulation. Gray lines represent GRO-seq data for individual genes, and blue
lines represent the mean of the individual traces.
(C) Box and whiskers plot showing the E2-dependent fold change for genes in each of the four classes.
(D) Correlation between fold changes measured by GRO-seq and expression microarrays for genes that show a change in the microarray analyses.
(E) Comparison of GRO-seq data to mRNA expression measured by RT-qPCR. Blue lines represent the mean of the GRO-seq data for the genes analyzed. Gray
lines represent RT-qPCR data for individual genes, and red lines indicate the mean.
See also Figure S3 and Table S1.changes in the steady-state levels of the corresponding mRNAs.
The correspondence was strongest for the downregulated and
the 40 min max GRO-seq classes (>80% of genes assayed
showed corresponding changes) and weaker for the 10 min
max and 160 min max classes (50% of genes assayed showed
corresponding changes). The discrepancies between transcrip-
tion and steady-state mRNA levels may be due to inherent insta-bility of certain nascent transcripts, which prevents them from
generating mature transcripts. Alternatively, they may reflect
active posttranscriptional regulation of specific transcripts
(e.g., by miRNAs; see below). Interestingly, we identified
a number of cases for each GRO-seq time point in which
E2-dependent changes in transcription were accompanied by
corresponding changes in the levels of the cognate protein,Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc. 627
including the 10 min max group (e.g., KRT19, MYC, and VDR;
Figures S3D and S3E).
Gene ontology (GO) analyses of the four classes of genes re-
vealed a similar pattern of enrichment in gene ontological cate-
gories for the downregulated and 40 min max classes (Tables
S1AandS1C),whichdiffer fromoradd to thosederivedpreviously
from microarray expression analyses (Carroll et al., 2006; Frasor
et al., 2003). Specifically, there was a significant enrichment in
GO terms related to transcription, nucleic acid metabolism, cell
surface receptor, and G protein-coupled signaling. The fact that
the same GO terms but different genes are regulated in both the
major up- and downregulated classes suggests a switch from
one cellular signaling program (e.g., serum response) to another
(i.e., estrogen signaling); each pathway may require the same
functional categories of genes but use a distinct set of genes
within each category. Interestingly, the 160 min max class was
significantly enriched inGO terms related to ribosomebiogenesis,
translation, and protein synthesis (discussed and elaborated
below) (Table S1D), whereas a very modest enrichment of GO
terms was observed for the 10 min max class (Table S1B).
Together, our results show that the transcriptional response to
estrogen signaling for protein-coding genes (and other classes
of transcripts, as well; see below) is rapid, extensive, and tran-
sient. This represents a different view of the estrogen response
than has been provided bymicroarray expression studies, which
have suggested a continually increasing set of regulated genes
in response to E2 treatment, many of which are likely to be
secondary or tertiary effects (Figure S3A).
Pol II Dynamics in Response to E2
Because the transcriptional response for protein-coding genes
to estrogen signaling was rapid and transient, we explored the
dynamics of Pol II at the promoters of the four classes defined
in the hierarchical clustering analysis. We performed metagene
analyses across the promoter regions of each class from
4 kb to +4 kb for each treatment time point (Figure 4A). The
peak of reads in the immediate vicinity of TSS indicates the pres-
ence, on average, of engaged Pol II before and after E2 treat-
ment. The decrease (or increase) of reads in the downstream
region indicates the downregulation (or upregulation) of tran-
scription in response to E2. This presentation of the GRO-seq
results highlights the following: on average, (1) loading of Pol II
at the TSSs of upregulated genes increases in response to E2
treatment, (2) divergent transcription of the upregulated genes
increases in response to E2 treatment, (3) downregulation
affects primarily Pol II in the gene bodies, and (4) loading of
Pol II at the TSSs and divergent transcription largely follow the
Pol II response in the body of the gene.
The increase in Pol II loading at the TSS in response to E2
suggests that Pol II loads more rapidly than it escapes into the
body of the gene for these classes of E2-regulated genes. This
is especially evident between the 10 and 40 min time points for
the 40 min max genes and between the 40 and 160 min time
points for the 160 min max genes, for which we see increased
Pol II loading at the earlier time point followed by an appreciable
increase in Pol II in the body of the gene at the later time point.
This ‘‘delayed’’ pattern of loading and escape is perhaps unex-
pected for the 160 min max genes, as the pausing of Pol II in628 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.the promoter proximal region is thought to allow rapid activation
of transcription in response to cellular signaling (Lis, 1998). Alter-
natively, such a response fits well with a recent suggestion that
pausing of Pol II in the promoter proximal region allows synchro-
nous gene activation (Boettiger and Levine, 2009).
ThedynamicsofPol II canalsobeclearly observed in examples
from specific up- and downregulated genes (Figures 4B and 4C
and Figure S4). With E2 upregulated genes, the leading edge of
a Pol II wave was observed traveling into the gene body upon
E2 treatment (Figure 4B). In contrast, with E2 downregulated
genes, the lagging edge of a Pol II wave was observed as the
polymerases were cleared from the TSS (Figure 4C). The results
from our GRO-seq analysis have provided an unprecedented
view of the Pol II dynamics in response to a sustained signal.
Regulation of miRNA Gene Transcription by Estrogen:
Parallels to the Regulation of Protein-Coding Genes
Our GRO-seq approach also provides considerable information
regarding the transcriptional regulationofprimarymicroRNA tran-
scripts. MicroRNAs (miRNAs) are 22 nt noncoding regulatory
RNAs thatmediate posttranscriptional regulation of gene expres-
sion by inhibiting the translation or promoting the degradation of
target mRNAs. miRNA precursor transcripts (pri-miRNAs) are
generated by Pol II, or in some cases Pol III, either as part of
a ‘‘host’’ gene in which they are embedded or from an intergenic
region using their own promoter (Krol et al., 2010). Using our
GRO-seq data set, we explored the regulation of pri-miRNA
gene transcription by E2. We unambiguously identified 322 ex-
pressed miRNA-containing transcripts in our data set based on
miRBase ver. 14. Of these, 119 (37%) were regulated by E2
during at least one time point (FDR q value < 0.001). Regulated
pri-miRNAs included some previously published estrogen-regu-
latedmiRNAs, includingmir-181a,mir-181b, andmir-21. Overall,
the pattern of regulation depicted in the heatmap shown in Fig-
ure 5A mirrors that observed for the protein-coding transcripts
(i.e., approximately half upregulated and half downregulated),
which is consistent with a large fraction being processed from
protein-coding transcripts. Examples of the transcriptional
response of specific pri-miRNAs are shown in Figure 5B. The
primary transcript of both examples is considerably larger than
the processed miRNA. Therefore, as with the protein-coding
genes, the leading (or lagging) edge of the polymerase wave
can be seen during the transcriptional response of the upregu-
lated (or downregulated) genes. Together, these results suggest
that the transcription of pri-miRNA genes is regulated by E2 in
asimilar pattern andwithsimilar kineticsasprotein-codinggenes.
Next, we determined whether estrogen stimulation involves
a coordinated response between pri-miRNA transcripts and
the protein-coding genes that they ultimately regulate. For this
analysis, we reasoned that the subset pri-miRNAs undergoing
long-lasting and relatively large regulatory changes are the
most likely to be reflected as changes in processed, mature
miRNA. Therefore, we focused on 47 of the 119 (40%) regu-
lated pri-miRNA transcripts that show more than 3-fold up- or
downregulation. These 47 robustly E2-regulated pri-miRNAs
potentially target 2700 mRNAs according to the TargetScan
database (Grimson et al., 2007; Lewis et al., 2005), or 12.8%
of RefSeq annotated mRNAs.
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Figure 4. GRO-Seq Reveals the Dynamics of E2-Dependent Transcription
(A) Metagene representations showing the average profile of GRO-seq sequence reads near and at the TSSs of RefSeq genes in each of the four classes during
the E2 treatment time course.
(B and C) Gene-specific views of the leading (B) and lagging (C) edges of a Pol II ‘‘wave’’ shown for the upregulated gene JARID2 (B) and the downregulated gene
ESR1 (C), respectively, during the E2 treatment time course.
See also Figure S4.Interestingly, as shown in Figure 5C, MCF-7 cells express
a larger fraction of the 2700 target mRNAs than expected,
such that 16.6% of expressed genes are targets of these
miRNAs (p = 3.7 3 1014; Fisher’s exact test). This enrichment
is consistent with an integrated regulatory program between
the miRNAs expressed in a cell and the corresponding
mRNA targets, consistent with previous suggestions (Farhet al., 2005). Importantly, the subset of genes regulated by
E2 is enriched even further over those genes that are ex-
pressed by the cell, such that 18.6% of E2-regulated mRNAs
are targets of E2-regulated pri-miRNAs (p = 0.03) (Figure 5C).
Moreover, this pattern of enrichment was also discovered
when selecting a smaller set of miRNAs that are > 5-fold regu-
lated by E2 (p = 0.02) or taking all miRNA transcriptsCell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc. 629
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Figure 5. E2 Regulates the Transcription of Primary miRNA Genes
(A) Heatmap of the time course of E2-dependent regulation of primary miRNA transcripts.
(B) Gene-specific examples of downregulated (left) and upregulated (right) primarymiRNA genes. Called transcripts and annotations are shown. In the right panel,
the ‘‘+ strand’’ called transcript (red) is actually the number of smaller called transcripts that, at the resolution used to represent this region, appear as one transcript.
(C) Fraction of the specified subset of annotated genes that are predicted to be targets of an E2-regulated miRNA based on TargetScan. Bars with different
superscripts are significantly different by Fisher’s exact test (p = 3.7 3 1014 for a/b; p = 0.03 for b/c; p = 1.8 3 1013 for a/c).
(D) (Left) GRO-seq data for pri-miRNA transcripts that are upregulated (bottom) or downregulated (top)R 3-fold by E2. Gray lines, data for individual genes; blue
lines, average for all genes. (Middle and right) GRO-seq (middle) and expression microarray (right) data for all of the potential targets of miRNAs encoded by the
pri-miRNA transcripts shown in the left panels. Faded red, black, and blue lines, data for individual upregulated, unregulated, and downregulated genes,
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respectively.
See also Figure S5.regardless of their fold change (p = 0.003), indicating that our
results are robust to the threshold chosen for the analysis. We
found no evidence that E2 specifically coordinates the tran-
scriptional regulation of pri-miRNAs with the direction (i.e.,
up or down) of regulation of their potential target mRNAs,
either by GRO-seq (Figure 5D, middle) or by expression micro-
arrays (Figure 5D, right). In fact, we found evidence for both
coordinated and compensatory regulation (Figure 5D; see Fig-
ure S5 for a detailed explanation). Together, these results
suggest an integrated regulatory program for E2-regulated
transcription of pri-miRNA transcripts and the mRNAs targeted
by the mature miRNAs.630 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.Dramatic Upregulation of the Protein Biosynthetic
Machinery by Estrogen Signaling
Because our GO analyses showed enrichment in genes with
a primary biological function in protein biosynthesis, we asked
whether E2 signaling has a broader effect on the protein biosyn-
thetic machinery. GRO-seq provides a measure of all three
eukaryotic polymerases; we therefore extracted and analyzed
the data for changes in the 45S rRNA (RNA Pol I) and tRNAs
(Pol III) annotated in the rnaGene track in the UCSC genome
browser. Our analysis revealed that the transcription of Pol I
and Pol III transcripts shows a similar pattern of regulation by
E2: (1) an initial burst at 10 min, (2) a slight decrease at 40 min,
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(A) E2-dependent fold change in the transcription of the 45S rDNA (Pol I) and
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(B and C) Heatmap of the time course of E2-dependent regulation of tRNA
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See also Figure S6.and (3) amaximal increase at 160min (Figures 6A and 6D). These
rapid effects are indicative of a primary, rather than secondary,
transcriptional response to estrogen signaling.For individual tRNA genes, changes were strongly biased
toward upregulation, with the transcription of > 90% of the
tRNA genes showing upregulation (Figure 6B). Furthermore,
this regulation unambiguously affects 158 of the 486 functional
annotated tRNA genes (32%) in at least one of the time points.
If the cell is indeed regulating tRNA genes in order to facilitate
an increase in translation, onemay expect that all 20 amino acids
will be upregulated. Indeed, we found that, of the 158 upregu-
lated tRNA genes, at least one tRNA gene coding for each of
the 20 amino acids is represented (p = 0.0012; Fisher’s exact
test) (Figure S6A). In addition to the 20 primary amino acids,
we also found the tRNA coding for the amino acid variant seleno-
cysteine, which is thought to play a role in antioxidant activity and
hormone biosynthesis (Stadtman, 1996), to be regulated by E2.
Because each three-letter combination of codons is represented
multiple times in the 486 annotated tRNA genes, we also asked
whether E2 regulates a larger fraction of the 64 possible codon
combinations than expected by chance. Indeed, we find that
64%of the 64 codon combinations are unambiguously regulated
by E2, which is more than expected based on our ability to call
32% of tRNA genes as regulated (p = 0.0027; Fisher’s exact
test). These results demonstrate that the observed changes in
the protein biosynthetic machinery are applied in a robust and
coordinated manner across amino acid and codon variations.
We also conducted amore focused analysis of protein-coding
genes with functions or cellular localization suggesting a role in
protein biosynthesis (e.g., ribosome biogenesis, tRNA aminoa-
cetylation, etc.; see Figure S6B for all GO terms used). As we
observed for tRNA genes, protein-coding genes represented in
these groups are strongly biased toward upregulation (Fig-
ure 6C). As suggested by the GO analysis above, these genes
are strongly enriched in the 160 min max class (p = 6.7 3
1013; Fisher’s exact test), suggesting that these are sustained
effects that translate the widespread changes observed in the
cellular transcriptome to the proteome.
Taken together, these results demonstrate a potent effect of
estrogen signaling on the protein biosynthetic machinery, which
fitswell with the knownmitogenic effects of E2 onMCF-7 cells. In
addition, they highlight the fact that estrogen signaling has
strong, immediate, and likely direct effects on transcription by
all three RNA polymerases, not just Pol II. Upregulation of the
protein biosynthetic machinery is likely a means by which the
estrogen-signaling pathway prepares the cell for translation of
the protein-coding transcripts that are newly synthesized in
response to estrogen signaling.
Relationship of ERa-Binding Sites to Primary Estrogen
Target Genes
Although most ERa-binding sites are located distal to the
promoters of protein-coding genes, a small but highly significant
enrichment of ERa-binding sites has been observed in the prox-
imal promoters of upregulated genes (Carroll et al., 2005, 2006),
consistent with a direct role of ERa in mediating their regulation.
Because our GRO-seq data reflect the direct transcriptional
output of the cell and because our shorter treatment times
make it unlikely that we will detect secondary changes in tran-
scription, we reasoned that we should observe that a larger frac-
tion of the genes that are regulated by GRO-seq are nearCell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc. 631
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Figure 7. ERa-Binding Sites Are Enriched in
the Promoters of Primary E2 Target Genes
(A) The fraction of the specified subset of
RefSeq genes with an ERa-binding site found
within 10 kb of the TSS. Bars with different
superscripts are significantly different by Fisher’s
exact test (p < 1.2 3 1012).
(B) The fraction of the specified transcript class
defined at 40 min. E2 treatment that initiates near
an ERa-binding site or an ERE.
(C) The fraction of ERa-binding sites found within
1 kb of either all well-annotated RefSeq genes or
the specified subset of de novo transcript anno-
tations determined by GRO-seq analysis.ERa-binding sites. To test this hypothesis, we used existing ERa
ChIP-seq data (Welboren et al., 2009) to determine the fraction of
E2-regulated RefSeq genes with a proximal ERa-binding site
(<10 kb to the transcription start site). Indeed, we found that
46% of genes upregulated by E2 at shorter time points (i.e., 10
and 40 min) contain an ERa-binding site within 10 kb of the tran-
scription start site.
Interestingly, when we analyzed the four classes of RefSeq
genes (i.e., 10, 40, 160 min max, and downregulated) separately,
we found striking differences in binding site enrichment between
these classes (Figure 7A). In particular, almost half of the genes in
the 40 min max class are located within 10 kb of an ERa-binding
site, a striking enrichment over the 10% found for RefSeq
genes in general (p < 2.2 3 1016; Fisher’s exact test). Genes
in the 10 min max class are also substantially enriched for prox-
imal ERa-binding sites (33%; p = 1.2 3 1012). Upregulated
genes that peak after 160 min have a lower level of enrichment
that is not statistically significant (12%; p = 0.24), suggesting
that a substantial fraction of this subset of genes reflects
secondary effects. Conversely, downregulated genes were
slightly less likely than average to be located within 10 kb of an
ERa-binding site (8%; p = 0.01). This observation strongly
suggests that E2 mediates up- and downregulation by different
mechanisms and that immediate upregulated genes tend to be
the direct genomic targets of ERa. Those E2-regulated genes
that do not have a proximal ERa-binding site may be regulated
by (1) other promoter-proximally bound transcription factors
acting as endpoints of membrane-initiated E2-signaling path-
ways or (2) looping from distal ERa enhancers to the promoters.
Looking more broadly across the transcript classes, we found
that the sets defined at 40 min of E2 treatment show a greater
enrichment of both ERa-binding sites and EREs than the sets632 Cell 145, 622–634, May 13, 2011 ª2011 Elsevier Inc.defined at the other time points. Interest-
ingly, whereas the percentage of tran-
scripts initiating near a bioinformatically
defined estrogen response element
(ERE) is not greatly enriched compared
to all RefSeq transcripts and is relatively
constant across the transcript classes
(i.e., 30%–50%), the percentage of
transcripts initiating near an experimen-
tally defined ERa-binding site varies
considerably (Figure 7B). We observedthe greatest enrichment of ERa-binding sites, compared to all
RefSeq, near the initiation sites for annotated, antisense, diver-
gent, and enhancer transcripts, suggesting similar modes of
E2-dependent regulation as were observed for the protein-
coding transcripts (Figure 7B).
We next determined the fraction of all ERa-binding sites that
map within the proximal promoter (<1 kb) for each class of tran-
script defined in our GRO-seq analysis (i.e., looking from an
ERa-binding site-centric view, as opposed to the transcript-
centric view above). We found that 18% of all ERa-binding
sites fall near transcripts detected using our HMM inMCF-7 cells
(Figure 7C). This includes 5%–6% of ERa-binding sites near
transcripts matching annotated genes that were specifically
found to be expressed in MCF-7 cells using our approach (Fig-
ure 7C, orange bar), as well as an additional 12% of ERa-bind-
ing sites found in the proximal promoters of genes producing
transcripts that are not currently annotated in public databases
(i.e., antisense, divergent, and enhancer transcripts). Though
this finding still suggests that long-range enhancer-promoter
interactions play a pivotal role in actions of ERa, as suggested
previously (Fullwood et al., 2009; Pan et al., 2008; Theodorou
and Carroll, 2010), it demonstrates a 3- to 4-fold increase in
the fraction of ERa-binding sites that are located near TSSs.
Collectively, our results provide a new view of signal-depen-
dent transcription events that suggest new questions and new
ways of thinking about specific aspects of the transcriptional
response.EXPERIMENTAL PROCEDURES
Additional details about the experimental procedures can be found in the
Supplemental Information.
Cell Culture
MCF-7 cells were maintained and propagated as described previously (Kininis
et al., 2009).
Generation and Analysis of GRO-Seq Libraries
GRO-seq was performed as described previously (Core et al., 2008), with
limited modifications. The data are available from the NCBI’s Gene Expression
Omnibus (accession number GSE27463), and the scripts are available upon
request from the corresponding author.
Generation of GRO-Seq Libraries
Libraries were generated from two biological replicates of MCF-7 cells grown
in estrogen-freemedium and treatedwith 100 nME2 as indicated. The libraries
were sequenced using an Illumina Genome Analyzer.
Transcript Calling and Annotation
Short-reads were aligned to the human reference genome (hg18, NCBI36),
including autosomes, X chromosome, and one complete copy of an rDNA
repeat (GenBank ID: U13369.1) using SOAP2 (Li et al., 2009). A two-state
hidden Markov model (HMM) (Durbin et al., 1998) was used to call transcripts,
which were then divided into six distinct, nonoverlapping classes, which are
intended to describe the function of each transcript. Annotations were made
using the decision tree outlined in Figure S1E and based on a set of definitions
(Figure S1F).
Determining Estrogen Regulation of Called Transcripts
E2-dependent changes in gene expression were detected using the edgeR
package (v.1.4.1) (Robinson et al., 2010). For each GRO-seq time point, reads
were counted in a window at the 50 end of each transcript (+1 to +13 kb). Tran-
scripts that change between the vehicle control and the 10, 40, or 160min time
points were collected for analysis if they met a false discovery rate (FDR) cor-
rected q value threshold (q < 0.001), corresponding to an 0.1% false
discovery rate under the edgeR modeling assumptions.
Clustering, Time Course, and Classification of Temporal Profiles
We selected all genes with an FDR corrected q value of 0.001 at any point
during the time course for inclusion in the temporal analysis. Computations
were performed in the statistical package R, using the same pipeline that we
described previously (Danko and Pertsov, 2009).
Additional Genomic Analyses
In addition to the analyses described above, we performed a set of more
focused analyses, as described below. Unless otherwise noted, all computa-
tions were performed in R.
Gene Ontology Analyses
Gene ontology analyses were performed usingGoStat (http://gostat.wehi.edu.
au/; Beissbarth and Speed, 2004). All expressed genes were used as a back-
ground set to analyze GO terms for each class (p < 0.05).
Protein Biosynthesis-Associated Protein-Coding Genes
Protein-coding genes with a primary biological function or cellular compart-
ment associated with the ribosome were identified using the Gene Ontology
(GO) website (http://www.geneontology.org/) (Figure S6B).
Comparing E2-Induced Changes in Transcripts Called by GRO-Seq
to Changes Observed by ExpressionMicroarrays and Pol II ChIP-Seq
RawCEL files from existingmicroarray data sets collected using the Affymetrix
U133 platform were analyzed together using a previously described pipeline
(Danko and Pertsov, 2009). Normalized microarray data were compared to
read counts mapping to the +1 to +13 kb window of genes regulated by E2
during at least one point in the GRO-seq time course.
MicroRNA Analyses
We identified E2-regulated primary transcripts from our HMM transcript
prediction algorithm that contain known miRNAs as described above. Each
of these E2-regulated pri-miRNAs was associated with its regulatory targets
using the TargetScan database (Lewis et al., 2005). Additional analyses were
performed as described in the Supplemental Information.
Comparing the GRO-Seq Results to Known ERa-Binding Sites
For the 10,205 ERa-binding sites defined by Welboren et al. (2009), we calcu-
lated: (1) the fraction of genes in a particular class that are found within 10 kb of
an ERa-binding site (Figure 7A) or (2) the fraction of ERa-binding sitesmapping
to within 1 kb, 5 kb, or 10 kb from the 50 end of the nearest transcript identified
de novo using the HMM described above or in a public database (Figure 7B).Correlations between Primary Transcripts and Antisense/Divergent
Transcripts
Transcripts corresponding to sense/antisense or sense/divergent pairs were
collected, and the reads were counted and analyzed using R.
Metagene Analyses
We used metagene representations to illustrate the distribution of reads near
a ‘‘typical’’ transcription start site. Mathematically, we defined a metagene
as specified in the Supplemental Information.RT-qPCR Gene Expression Analyses
Changes in the steady-state levels of the E2-regulated geneswere analyzed by
RT-qPCR, as previously described (Kininis et al., 2009). The fold expression
changes were normalized to GAPDH as an internal standard.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at doi:10.
1016/j.cell.2011.03.042.ACKNOWLEDGMENTS
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